Comparison of receptor binding characteristics of commonly used muscarinic antagonists in human bladder detrusor and mucosa.
about
Medical management of neurogenic bladder with oral therapyThe pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder diseaseMirabegron: a Beta-3 agonist for overactive bladder.Role of fesoterodine in the treatment of overactive bladder.Fesoterodine for the treatment of overactive bladder.Acetylcholinesterase Inhibitors and Drugs Acting on Muscarinic Receptors- Potential Crosstalk of Cholinergic Mechanisms During Pharmacological Treatment
P2860
Comparison of receptor binding characteristics of commonly used muscarinic antagonists in human bladder detrusor and mucosa.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Comparison of receptor binding ...... n bladder detrusor and mucosa.
@en
Comparison of receptor binding ...... n bladder detrusor and mucosa.
@nl
type
label
Comparison of receptor binding ...... n bladder detrusor and mucosa.
@en
Comparison of receptor binding ...... n bladder detrusor and mucosa.
@nl
prefLabel
Comparison of receptor binding ...... n bladder detrusor and mucosa.
@en
Comparison of receptor binding ...... n bladder detrusor and mucosa.
@nl
P2093
P356
P1476
Comparison of receptor binding ...... an bladder detrusor and mucosa
@en
P2093
Arthur Christopoulos
Elizabeth Burcher
Frederick J Mitchelson
Jonathan J Chandran
Kenneth J Vaux
Richard J Millard
P304
P356
10.1124/JPET.108.145508
P407
P577
2008-11-24T00:00:00Z